Abstract
Visfatin, a novel adipokine, is predominantly produced by visceral adipose tissue and it has been linked to a diverse variety of cellular processes and it is an important factor in cell apoptosis and survival. Cerebral ischemia causes loss of hippocampus pyramidal cells. In this study, we investigated the neuroprotective effects of visfatin in rats after global cerebral ischemia. Both common carotid arteries were occluded for 20 min followed by reperfusion. Saline as a vehicle and visfatin at doses of 100 ng were injected intracerebro-ventriculary at the time of cerebral reperfusion. Apoptosis and necrosis were assessed 96 h after ischemia. The results showed that treatment with visfatin significantly reduces apoptosis (P < 0.05) and necrotic cell death (P < 0.001) in hippocampal CA3 area, compared to the ischemia group. In conclusion, visfatin treatment, found for the first time in the present study, reduces hippocampus CA3 injuries after cerebral ischemia through preventing neuronal necrosis and apoptosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Peptide Research and Therapeutics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
